| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 28-Sep-08 | | Total Revenue | 1,391,000 | 1,275,000 | 1,695,000 | 2,107,000 | | Cost of Revenue | 1,214,000 | 1,129,000 | 1,651,000 | 1,782,000 | | | Gross Profit | 177,000 | 146,000 | 44,000 | 325,000 | | | Operating Expenses | | Research Development | 15,000 | 13,000 | 15,000 | 14,000 | | Selling General and Administrative | (24,000) | 195,000 | 102,000 | 317,000 | | Non Recurring | 119,000 | 142,000 | 1,326,000 | 194,000 | | Others | 129,000 | 126,000 | 140,000 | 153,000 | | | | Total Operating Expenses | 239,000 | 476,000 | 1,583,000 | 678,000 | | | | Operating Income or Loss | (62,000) | (330,000) | (1,539,000) | (353,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,000) | (2,000) | 153,000 | 30,000 | | Earnings Before Interest And Taxes | (52,000) | (327,000) | (1,373,000) | (306,000) | | Interest Expense | 96,000 | 115,000 | 118,000 | 115,000 | | Income Before Tax | (148,000) | (442,000) | (1,491,000) | (421,000) | | Income Tax Expense | (32,000) | (176,000) | (314,000) | (221,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (116,000) | (266,000) | (1,177,000) | (200,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (35,000) | 480,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (116,000) | (266,000) | (1,212,000) | 280,000 | | Preferred Stock And Other Adjustments | 10,000 | 2,000 |
-
|
-
| | | Net Income Applicable To Common Shares | ($106,000) | ($264,000) | ($1,212,000) | $280,000 |
|
2.03% Nasdaq 
Income Statement
